Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways.
about
Gene × Environment Interactions in Schizophrenia: Evidence from Genetic Mouse ModelsAnimal models of gene-environment interaction in schizophrenia: A dimensional perspective.Long-term consequences of adolescent cannabinoid exposure in adult psychopathology.Mouse models of gene-environment interactions in schizophrenia.The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.Interneuron epigenomes during the critical period of cortical plasticity: Implications for schizophrenia.What does a mouse tell us about neuregulin 1-cannabis interactions?COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in cannabis users.The effects of Δ9-tetrahydrocannabinol on the dopamine system.Genetic models of schizophrenia and related psychotic disorders: progress and pitfalls across the methodological "minefield".Cannabis, the pregnant woman and her child: weeding out the myths.The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use DisordersAdolescent cannabinoid exposure effects on natural reward seeking and learning in rats.BDNF overexpression prevents cognitive deficit elicited by adolescent cannabis exposure and host susceptibility interaction.THC alters alters morphology of neurons in medial prefrontal cortex, orbital prefrontal cortex, and nucleus accumbens and alters the ability of later experience to promote structural plasticity.The Influence of DAT1, COMT, and BDNF Genetic Polymorphisms on Total and Subregional Hippocampal Volumes in Early Onset Heavy Cannabis Users.Adolescent synthetic cannabinoid exposure produces enduring changes in dopamine neuron activity in a rodent model of schizophrenia susceptibility.
P2860
Q28067507-232CB110-162B-4DF1-B15C-4CA5BD072B0DQ30367009-FFAE3838-E13C-4911-8E07-D264E0E4E8E0Q30424669-3A1E38C3-BCFD-432C-AD45-AC31BE0A2A22Q30432026-DD276662-7F3A-4E4E-B690-4180939503D5Q30437188-F475D2A7-6721-4FE4-8347-73A7E626FE97Q36055182-6E518A4C-81BB-4DA3-A744-653CA821E465Q36637021-4A786D3A-5EDF-45BA-9910-7A57E15F58E8Q36927785-2741D8CD-CAE1-4535-8242-B87255B97F32Q37441554-2EAE6F32-0CA1-493F-B9A6-0CE5D32A0DEFQ38110180-B44A4C48-92EA-41B9-8D7F-166098BEC5A8Q38181303-A567896E-9020-4E0E-AA08-E38C4D8EDA86Q38950639-DA8E7E40-F33E-446F-B898-2CFF625E3018Q46174181-9023DBB8-92D2-4874-A0D5-EC6DB1B8BAAFQ47750430-8DD92E16-55D0-417C-8088-DB12E953EBFBQ47948898-16C1EEA2-7AF8-4F0D-A022-F3A9722A34C0Q49271516-60DE85EF-1BD8-4B9D-9A50-96B2E1F88CB4Q50063042-207A6CAE-3931-41B4-B2D6-A6901B5F8751
P2860
Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Chronic adolescent exposure to ...... binoid and GABAergic pathways.
@ast
Chronic adolescent exposure to ...... binoid and GABAergic pathways.
@en
type
label
Chronic adolescent exposure to ...... binoid and GABAergic pathways.
@ast
Chronic adolescent exposure to ...... binoid and GABAergic pathways.
@en
prefLabel
Chronic adolescent exposure to ...... binoid and GABAergic pathways.
@ast
Chronic adolescent exposure to ...... binoid and GABAergic pathways.
@en
P2093
P2860
P921
P356
P1476
Chronic adolescent exposure to ...... binoid and GABAergic pathways.
@en
P2093
Aine T Behan
Anthony Kinsella
Colm M P O'Tuathaigh
David R Cotter
John L Waddington
Joseph A Gogos
Magdalena Hryniewiecka
Maria Karayiorgou
P2860
P2888
P304
P356
10.1038/NPP.2012.24
P407
P50
P577
2012-03-21T00:00:00Z
P5875
P6179
1003646609